Demonstration of IgG Subclass (IgG1 and IgG3) in Immuno-Related Hemocytopenia

被引:2
作者
Shao, Yuanyuan [1 ]
Qi, Xiao [1 ]
Fu, Rong [1 ]
Liu, Hui [1 ]
Wang, Yihao [1 ]
Ding, Shaoxue [1 ]
Wang, Huaquan [1 ]
Li, Lijuan [1 ]
Shao, Zonghong [1 ]
机构
[1] Tianjin Med Univ, Gen Hosp, Dept Hematol, 154 Anshan St, Tianjin 300052, Peoples R China
关键词
ICUS; immunoglobulin G; flow cytometry; immunohistochemistry;
D O I
10.7754/Clin.Lab.2018.180121
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Immuno-related hemocytopenia (IRH) is defined as idiopathic cytopenia of undetermined significance (ICUS) patients with autoantibodies. In our previous studies, we found that IgG1 levels were increased in IRH patients and might cause the destruction of hematopoietic cells. Methods: In this study, we analyzed IgG subclasses in 30 IRH patients (male:female = 13:17, median age 32 years, range 18 - 56), 15 IRH remission patients (IRH-R) (male:female = 6:9, median age 34, range 20 - 52) and 20 normal controls (male:female = 8:12, median age 27, range 24 - 36) by Cytometric Bead Array, Flow Cytometry and Immunohistochemical staining. Results: Levels of IgGl/IgG3 in the bone marrow supernatant of IRH patents, as well as the proportion of CD5+ B lymphocytes and Th2 cells (CD3+CD8-IL-4+) were higher than those of IRH-R patients and normal controls, and IgGl levels had a positive correlation with the proportion of Th2 cells. In IRH patients, IgGl and IgG3 were positive on nucleated erythrocytes and granulocytes, which were negative in IRH-R patients and healthy controls and had inverse correlations with hematopoietic function. Using immunohistochemical staining, IgGl were also detected on bone marrow biopsies of IRH patients. Conclusions: The results indicated that IgGl and IgG3 autoantibodies in IRH patients might play a key role in the IRH pathogenesis and in the abnormal immune function of IRH patients.
引用
收藏
页码:1041 / 1048
页数:8
相关论文
共 50 条
  • [31] Application of green fluorescent protein to affinity electrophoresis; Affinity of IgG-binding domain C from streptococcal protein G to mouse IgG1
    Kazama, H
    Yamada, K
    Aoki, T
    Watabe, H
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2002, 25 (02) : 168 - 171
  • [32] Specific IgM, IgG and IgG1 directed against Toxoplasma gondii detected by flow cytometry and their potential as serologic tools to support clinical indirect fundoscopic presumed diagnosis of ocular disease
    Martins, Livia Mattos
    Peixoto Rangel, Alba Lucinia
    Peixe, Ricardo Guerra
    Silva-dos-Santos, Priscila Pinto
    Lemos, Elenice Moreira
    Martins-Filho, Olindo Assis
    Garcia Bahia-Oliveira, Lilian Maria
    JOURNAL OF IMMUNOLOGICAL METHODS, 2015, 417 : 97 - 106
  • [33] IgG1 Allotypes Influence the Pharmacokinetics of Therapeutic Monoclonal Antibodies through FcRn Binding
    Ternant, David
    Arnoult, Christophe
    Pugniere, Martine
    Dhommee, Christine
    Drocourt, Daniel
    Perouzel, Eric
    Passot, Christophe
    Baroukh, Nadine
    Mulleman, Denis
    Tiraby, Gerard
    Watier, Herve
    Paintaud, Gilles
    Gouilleux-Gruart, Valerie
    JOURNAL OF IMMUNOLOGY, 2016, 196 (02) : 607 - 613
  • [34] Study on the scale-up of human IgG3 purification using protein A affinity chromatography
    Amaral, J
    Inganäs, M
    Cabral, J
    Prazeres, D
    BIOSEPARATION, 2001, 10 (4-5) : 139 - 143
  • [35] In Vitro Glycoengineering of IgG1 and Its Effect on Fc Receptor Binding and ADCC Activity
    Thomann, Marco
    Schlothauer, Tilman
    Dashivets, Tetyana
    Malik, Sebastian
    Avenal, Cecile
    Bulau, Patrick
    Rueger, Petra
    Reusch, Dietmar
    PLOS ONE, 2015, 10 (08):
  • [36] Protein A does not induce allosteric structural changes in an IgG1 antibody during binding
    Pabon, Juan P. Rincon
    Kochert, Brent A.
    Liu, Yan-Hui
    Richardson, Douglas D.
    Weis, David D.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 110 (06) : 2355 - 2361
  • [37] Natural Human Immunity Against Staphylococcal Protein A Relies on Effector Functions Triggered by IgG3
    Boero, Elena
    Cruz, Ana Rita
    Pansegrau, Werner
    Giovani, Cinzia
    Rooijakkers, Suzan H. M.
    van Kessel, Kok P. M.
    van Strijp, Jos A. G.
    Bagnoli, Fabio
    Manetti, Andrea G. O.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [38] Glycoengineering design options for IgG1 in CHO cells using precise gene editing
    Schulz, Morten A.
    Tian, Weihua
    Mao, Yang
    Van Coillie, Julie
    Sun, Lingbo
    Larsen, Joachim S.
    Chen, Yen-Hsi
    Kristensen, Claus
    Vakhrushev, Sergey Y.
    Clausen, Henrik
    Yang, Zhang
    GLYCOBIOLOGY, 2018, 28 (07) : 542 - 549
  • [39] Phase Separation of an IgG1 Antibody Solution under a Low Ionic Strength Condition
    Nishi, Hirotaka
    Miyajima, Makoto
    Nakagami, Hiroaki
    Noda, Masanori
    Uchiyama, Susumu
    Fukui, Kiichi
    PHARMACEUTICAL RESEARCH, 2010, 27 (07) : 1348 - 1360
  • [40] Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid
    Manfred Wuhrer
    Maurice H. J. Selman
    Liam A. McDonnell
    Tania Kümpfel
    Tobias Derfuss
    Mohsen Khademi
    Tomas Olsson
    Reinhard Hohlfeld
    Edgar Meinl
    Markus Krumbholz
    Journal of Neuroinflammation, 12